---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-064545"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2026-05-20T20:30:26+00:00"
generated_at: "2026-05-20T20:51:56.936820+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve increase in stock option plan shares by 900,000 at 2026 annual meeting

## Summary
- All 7 director nominees elected; broker non-votes of 614,643.
- Ratification of Baker Tilly as auditor approved: 4,657,634 for, 4,415 against.
- Amendment to 2025 Plan increases shares available to 1,017,868 from 117,868.
- Shareholders representing 53.1% of outstanding common shares present at meeting.

## SEC filing metadata
- accession: 0001104659-26-064545
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2026-05-20T20:30:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/0001104659-26-064545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/pmn-20260520x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-064545
- JSON: https://secwatch.observer/filing/0001104659-26-064545.json
- Plain text: https://secwatch.observer/filing/0001104659-26-064545.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.